PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa

Pseudomonas aeruginosa causes acute and chronic infections in human. Its increasing resistance to antibiotics requires alternative treatments that are more effective than available strategies. Among the alternatives is the unconventional usage of conventional antibiotics, of which the macrolide anti...

Full description

Bibliographic Details
Main Authors: Hao eTan, Lu eZhang, Yuding eWeng, Ronghao eChen, Feng eZhu, Yongxin eJin, Zhihui eCheng, Shouguang eJin, Weihui eWu
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-03-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00317/full
_version_ 1828329109386690560
author Hao eTan
Lu eZhang
Yuding eWeng
Ronghao eChen
Feng eZhu
Yongxin eJin
Zhihui eCheng
Shouguang eJin
Shouguang eJin
Weihui eWu
author_facet Hao eTan
Lu eZhang
Yuding eWeng
Ronghao eChen
Feng eZhu
Yongxin eJin
Zhihui eCheng
Shouguang eJin
Shouguang eJin
Weihui eWu
author_sort Hao eTan
collection DOAJ
description Pseudomonas aeruginosa causes acute and chronic infections in human. Its increasing resistance to antibiotics requires alternative treatments that are more effective than available strategies. Among the alternatives is the unconventional usage of conventional antibiotics, of which the macrolide antibiotic azithromycin (AZM) provides a paradigmatic example. AZM therapy is associated with a small but consistent improvement in respiratory function of cystic fibrosis (CF) patients suffering from chronic P. aeruginosa infection. Besides immunomodulating activities, AZM represses bacterial genes involved in virulence, quorum sensing, biofilm formation, and motility, all of which are due to stalling of ribosome and depletion of cellular tRNA pool. However, how P. aeruginosa responds to and counteracts the effects of AZM remain elusive. Here we found that deficiency of PA3297, a gene encoding a DEAH-box helicase, intensified AZM-mediated bacterial killing, suppression of pyocyanin production and swarming motility, and hypersusceptibility to hydrogen peroxide. We demonstrated that expression of PA3297 is induced by the interaction between AZM and ribosome. Importantly, mutation of PA3297 resulted in elevated levels of unprocessed 23S-5S rRNA in the presence of AZM, which might lead to increased susceptibility to AZM-mediated effects. Our results revealed one of the bacterial responses in counteracting the detrimental effects of AZM.
first_indexed 2024-04-13T20:20:03Z
format Article
id doaj.art-3b72980cacb149298c91a1db369c25ba
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-13T20:20:03Z
publishDate 2016-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-3b72980cacb149298c91a1db369c25ba2022-12-22T02:31:34ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2016-03-01710.3389/fmicb.2016.00317182864PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosaHao eTan0Lu eZhang1Yuding eWeng2Ronghao eChen3Feng eZhu4Yongxin eJin5Zhihui eCheng6Shouguang eJin7Shouguang eJin8Weihui eWu9State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityCollege of Medicine, University of FloridaState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai UniversityPseudomonas aeruginosa causes acute and chronic infections in human. Its increasing resistance to antibiotics requires alternative treatments that are more effective than available strategies. Among the alternatives is the unconventional usage of conventional antibiotics, of which the macrolide antibiotic azithromycin (AZM) provides a paradigmatic example. AZM therapy is associated with a small but consistent improvement in respiratory function of cystic fibrosis (CF) patients suffering from chronic P. aeruginosa infection. Besides immunomodulating activities, AZM represses bacterial genes involved in virulence, quorum sensing, biofilm formation, and motility, all of which are due to stalling of ribosome and depletion of cellular tRNA pool. However, how P. aeruginosa responds to and counteracts the effects of AZM remain elusive. Here we found that deficiency of PA3297, a gene encoding a DEAH-box helicase, intensified AZM-mediated bacterial killing, suppression of pyocyanin production and swarming motility, and hypersusceptibility to hydrogen peroxide. We demonstrated that expression of PA3297 is induced by the interaction between AZM and ribosome. Importantly, mutation of PA3297 resulted in elevated levels of unprocessed 23S-5S rRNA in the presence of AZM, which might lead to increased susceptibility to AZM-mediated effects. Our results revealed one of the bacterial responses in counteracting the detrimental effects of AZM.http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00317/fullAzithromycinPseudomonas aeruginosaantibiotic resistanceRNA helicaserRNA processing
spellingShingle Hao eTan
Lu eZhang
Yuding eWeng
Ronghao eChen
Feng eZhu
Yongxin eJin
Zhihui eCheng
Shouguang eJin
Shouguang eJin
Weihui eWu
PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
Frontiers in Microbiology
Azithromycin
Pseudomonas aeruginosa
antibiotic resistance
RNA helicase
rRNA processing
title PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
title_full PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
title_fullStr PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
title_full_unstemmed PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
title_short PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
title_sort pa3297 counteracts antimicrobial effects of azithromycin in pseudomonas aeruginosa
topic Azithromycin
Pseudomonas aeruginosa
antibiotic resistance
RNA helicase
rRNA processing
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00317/full
work_keys_str_mv AT haoetan pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT luezhang pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT yudingeweng pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT ronghaoechen pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT fengezhu pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT yongxinejin pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT zhihuiecheng pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT shouguangejin pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT shouguangejin pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa
AT weihuiewu pa3297counteractsantimicrobialeffectsofazithromycininpseudomonasaeruginosa